 |
市场调查报告书
商品编码
1793324
全球动物感染疾病诊断市场（按产品、技术、动物类型、最终用户和地区划分）- 预测至 2030 年Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030 |
||||||
价格
动物感染疾病诊断市场预计将从 2025 年的 28.7 亿美元成长到 2030 年的 42.2 亿美元，复合年增长率为 8.0%。
这种增长是由反映动物健康和疾病管理变化的几个关键因素所推动的。
| 调查范围 | |
|---|---|
| 调查年份 | 2024-2030 |
| 基准年 | 2024 |
| 预测期 | 2025-2030 |
| 对价单位 | 金额（十亿美元） |
| 按细分市场 | 按产品、按技术、按动物类型、按最终用户、按地区 |
| 目标区域 | 北美、欧洲、亚太地区、拉丁美洲、中东和非洲 |
伴侣动物和牲畜感染疾病负担日益加重，推动了对快速、可靠且可现场部署的诊断解决方案的需求。禽流感、钩端螺旋体病和布氏桿菌症等疾病的爆发日益频繁，促使兽医和动物生产者优先考虑早期准确的检测，以降低风险。
另一个重要因素是向预防性兽医护理的转变。随着宠物饲主和牲畜饲养者意识的增强，他们更加重视定期检测和健康监测，以便在感染传播之前发现它们。这一趋势也源于人们对通用感染疾病传播相关的经济和公共卫生影响的认识不断提高。
伴侣动物领域预计将成为动物感染疾病诊断市场中成长最快的领域，这得益于宠物主人数量的不断增长，尤其是在都市区高所得家庭中。由于人们对通用感染疾病的认识不断提高，以及早期发现的重要性，宠物饲主愿意投资健康身体检查和诊断服务。此外，即时诊断和家用诊断工具的技术创新也提高了宠物饲主和兽医的可近性。由于兽医就诊频率的不断提高以及宠物医疗保健支出的不断增长，预计该领域将迎来快速增长。
2024年，感染疾病诊断市场因其成本效益和高准确性而占据主导地位。 ELISA和横向流动化验等技术通常用于检测伴侣动物和牲畜的各种感染疾病。这些检测方法快速出结果，易于使用，且所需设备极少，是兽医诊所和现场应用的理想选择。它们能够检测特定抗原和抗体，从而实现早期诊断和有效的疾病管理，因此对于大规模群体筛检和常规监测计画具有重要价值。
由于人口、经济和医疗保健等许多因素，亚太地区预计将成为动物传染病诊断市场成长最快的地区。该地区庞大的牲畜存栏量推动了对精准诊断的需求，以应对口蹄疫和禽流感等感染疾病的蔓延。此外，伴侣动物数量的成长，尤其是在中国和印度的都市区，也推动了兽医医疗保健支出的成长。兽医基础设施的加强、人们对通用感染疾病威胁的认识不断提高以及对动物健康的投资也促进了市场的成长。各公司正在扩大在该地区的业务，以改善其获得先进诊断技术的管道。
本报告研究了全球动物感染疾病诊断市场，按产品、技术、动物类型、最终用户和地区进行细分，并提供了参与市场的公司概况。
目录
第一章 引言
第二章调查方法
第三章执行摘要
第四章重要考察
第五章市场概述
- 市场动态
- 产业趋势
- 技术分析
- 波特五力分析
- 监管分析
- 专利分析
- 贸易分析
- 定价分析
- 报销分析
- 2025-2026年主要会议和活动
- 主要相关人员和采购标准
- 最终使用者的观点和未满足的需求
- 人工智慧对动物感染疾病诊断市场的影响
- 生态系分析
- 价值链分析
- 供应链分析
- 邻近市场分析
- 投资金筹措场景
- 2025年美国关税对动物感染疾病诊断市场的影响
第六章动物感染疾病诊断市场（依产品）
- 介绍
- 耗材
- 装置
第七章动物感染疾病诊断市场（依技术）
- 介绍
- 免疫诊断
- 分子诊断
- 其他的
第八章动物感染疾病诊断市场（依动物类型）
- 介绍
- 伴侣动物
- 家畜
第九章动物感染疾病诊断市场（依最终用户）
- 介绍
- 兽医参考实验室
- 兽医医院和诊所
- 照护现场/内部侦测
- 兽医研究机构和大学
第十章 动物感染疾病诊断市场（按地区）
- 介绍
- 北美洲
- 北美宏观经济展望
- 美国
- 加拿大
- 欧洲
- 欧洲宏观经济展望
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 荷兰
- 其他的
- 亚太地区
- 亚太宏观经济展望
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 纽西兰
- 越南
- 其他的
- 拉丁美洲
- 拉丁美洲宏观经济展望
- 巴西
- 墨西哥
- 其他的
- 中东和非洲
- 中东和非洲宏观经济展望
- 海湾合作委员会国家
- 其他的
第十一章竞争格局
- 概述
- 主要参与企业的策略/优势
- 2020-2024年收益分析
- 2024年市场占有率分析
- 公司估值矩阵：2024 年关键参与企业
- 公司估值矩阵：Start-Ups/中小企业，2024 年
- 品牌/产品比较
- 主要企业研发支出
- 估值和财务指标
- 竞争场景
第十二章：公司简介
- 主要参与企业
- IDEXX LABORATORIES, INC.
- ZOETIS SERVICES LLC
- THERMO FISHER SCIENTIFIC INC.
- VIRBAC
- BIOMERIEUX
- ANTECH DIAGNOSTICS, INC.
- INNOVATIVE DIAGNOSTICS
- NEOGEN CORPORATION
- INDICAL BIOSCIENCE GMBH
- AGROLABO SPA
- BIONOTE
- BIOGAL
- BIOCHEK
- MEGACOR DIAGNOSTIK GMBH
- BIO-RAD LABORATORIES, INC.
- 其他公司
- FASSISI, GMBH
- BIOTANGENTS LIMITED
- SKYER, INC.
- BIOPANDA REAGENTS LTD.
- SHENZHEN BIOEASY BIOTECHNOLOGY, INC.
- GOLD STANDARD DIAGNOSTICS
- BIO-X DIAGNOSTICS SA
- DEMEDITEC DIAGNOSTICS GMBH
- EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
- BIOSTONE ANIMAL HEALTH
第十三章 附录
Product Code: MD 7211
The veterinary infectious disease diagnostics market is expected to grow from USD 2.87 billion in 2025 to USD 4.22 billion by 2030, at a CAGR of 8.0%. This growth is driven by several important factors that reflect the changing landscape of animal health and disease management.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2024-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD billion) |
| Segments | By Product, Technology, Animal Type, End User, Region |
| Regions covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
One primary driver is the increasing burden of infectious diseases among both companion animals and livestock, which has heightened the need for rapid, reliable, and field-deployable diagnostic solutions. The rise in outbreaks of diseases such as avian influenza, leptospirosis, and brucellosis is leading veterinarians and animal producers to prioritize early and accurate detection to mitigate risks.
Another significant factor is the shift towards preventive veterinary care. As awareness grows among pet owners and livestock handlers, there is a stronger emphasis on routine screenings and health monitoring to identify infections before they escalate. This trend is also supported by a growing recognition of the economic and public health consequences associated with the transmission of zoonotic diseases.
"By animal type, the companion animals segment is projected to grow at the highest CAGR during the forecast period."
The companion animals segment is expected to see the highest growth in the veterinary infectious disease diagnostics market, driven by increasing pet ownership, especially in urban high-income households. Pet owners are more willing to invest in health check-ups and diagnostic services due to the growing awareness of zoonotic diseases and the importance of early detection. Additionally, innovations in point-of-care and home-based diagnostic tools enhance access for both pet owners and veterinarians. With more frequent visits to veterinary clinics and rising healthcare spending for pets, this segment is projected for rapid growth in the market.
"By technology, the immunodiagnostics segment accounted for the largest market share in 2024."
In 2024, the immunodiagnostics segment dominated the veterinary infectious disease diagnostics market due to its cost-effectiveness and high accuracy. Techniques like ELISA and lateral flow assays are commonly used to detect various infectious diseases in companion and livestock animals. These tests provide rapid results, are user-friendly, and require minimal equipment, making them ideal for veterinary clinics and field use. Their ability to detect specific antigens or antibodies enables early diagnosis and effective disease management, making them valuable for large population screenings and routine surveillance programs.
"The Asia Pacific region is expected to witness the highest growth rate during the forecast period."
The Asia Pacific is set to experience the highest growth in the veterinary infectious disease diagnostics market due to various demographic, economic, and healthcare factors. The region's large livestock population drives the demand for accurate diagnostics to address rising infectious diseases like foot-and-mouth disease and avian influenza. Additionally, the increasing number of companion animals, especially in urban areas of China and India, is boosting veterinary healthcare spending. Enhanced veterinary infrastructure, heightened awareness of zoonotic threats, and investments in animal health are also contributing to market growth. Companies are expanding their presence in the region to improve access to advanced diagnostic technologies.
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
- By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
- By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)
Breakdown of demand-side primary interviews:
- By End User: Veterinary Reference Laboratories (40%), Veterinary Hospitals & Clinics (25%), POC/In-house Testing (20%), and Veterinary Research Institutes & Universities (15%)
- By Designation: Veterinary Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%)
- By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)
Research Coverage
The market study covers the veterinary infectious disease diagnostics market in various segments. It aims to estimate the market size and growth potential of this market by product, technology, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.
This report provides insights into the following points:
- Analysis of key drivers (growth in companion animal population, increasing demand for animal-derived food products, growing concerns about infectious zoonotic diseases, rising demand for pet insurance and growing animal health expenditures, increasing number of veterinary practitioners and rising income levels in developed markets, and growing focus on disease control and prevention measures), restraints (rising pet care costs and high cost of veterinary diagnostic tests), opportunities (growth potential of emerging economies and integration of AI and ML), and challenges (low animal healthcare awareness in emerging countries and shortage of veterinary practitioners in emerging economies) influencing the growth of the veterinary infectious disease diagnostics market.
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the veterinary infectious disease diagnostics market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of veterinary infectious disease diagnostic products across regions.
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary infectious disease diagnostics market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary infectious disease diagnostics market.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.4 MARKET STAKEHOLDERS
- 1.5 LIMITATIONS
- 1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH APPROACH
- 2.2 RESEARCH METHODOLOGY DESIGN
- 2.2.1 SECONDARY RESEARCH
- 2.2.1.1 Key data from secondary sources
- 2.2.2 PRIMARY DATA
- 2.2.2.1 Key data from primary sources
- 2.2.2.2 Key industry insights
- 2.2.1 SECONDARY RESEARCH
- 2.3 MARKET SIZE ESTIMATION
- 2.3.1 BOTTOM-UP APPROACH
- 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
- 2.5 MARKET SHARE ESTIMATION
- 2.6 RESEARCH ASSUMPTIONS
- 2.7 RISK ASSESSMENT
- 2.8 RESEARCH LIMITATIONS
- 2.8.1 METHODOLOGY-RELATED LIMITATIONS
- 2.8.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
- 4.2 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & COUNTRY (2024)
- 4.3 INFECTIOUS DISEASE DIAGNOSTICS MARKET: REGIONAL MIX
- 4.4 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 4.5 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEVELOPED VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
- 5.1 MARKET DYNAMICS
- 5.1.1 DRIVERS
- 5.1.1.1 Growth in companion animal population
- 5.1.1.2 Increasing demand for animal-derived food products
- 5.1.1.3 Growing concerns about infectious zoonotic diseases
- 5.1.1.4 Rising demand for pet insurance and growing animal health expenditure
- 5.1.1.5 Increasing number of veterinary practitioners and rising income levels in developed markets
- 5.1.1.6 Growing focus on disease control & prevention measures
- 5.1.2 RESTRAINTS
- 5.1.2.1 Rising pet care costs
- 5.1.2.2 High cost of veterinary diagnostic tests
- 5.1.3 OPPORTUNITIES
- 5.1.3.1 Growth potential of emerging economies
- 5.1.3.2 Integration of AI & ML
- 5.1.4 CHALLENGES
- 5.1.4.1 Low animal healthcare awareness in emerging countries
- 5.1.4.2 Shortage of veterinary practitioners in emerging economies
- 5.1.1 DRIVERS
- 5.2 INDUSTRY TRENDS
- 5.2.1 ADOPTION OF MULTIPLE TEST PANELS
- 5.2.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
- 5.2.3 GROWING SCALE OF VETERINARY BUSINESSES
- 5.3 TECHNOLOGY ANALYSIS
- 5.3.1 KEY TECHNOLOGIES
- 5.3.1.1 Portable instruments for POC diagnostic services
- 5.3.1.2 Biosensor-based diagnostic systems
- 5.3.2 ADJACENT TECHNOLOGIES
- 5.3.2.1 Wearable biosensors & remote monitoring devices
- 5.3.2.2 Rapid & sensitive veterinary diagnostic kits
- 5.3.2.3 Breath & saliva-based diagnostic tools
- 5.3.2.4 Microfluidics & Lab-on-a-chip devices
- 5.3.3 COMPLEMENTARY TECHNOLOGIES
- 5.3.3.1 AI-driven diagnostic platforms
- 5.3.3.2 Next-generation sequencing (NGS)
- 5.3.1 KEY TECHNOLOGIES
- 5.4 PORTER'S FIVE FORCES ANALYSIS
- 5.4.1 THREAT OF NEW ENTRANTS
- 5.4.2 THREAT OF SUBSTITUTES
- 5.4.3 BARGAINING POWER OF SUPPLIERS
- 5.4.4 BARGAINING POWER OF BUYERS
- 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.5 REGULATORY ANALYSIS
- 5.5.1 REGULATORY LANDSCAPE
- 5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.5.2.1 North America
- 5.5.2.2 Europe
- 5.5.2.3 Rest of the World
- 5.6 PATENT ANALYSIS
- 5.6.1 PATENT PUBLICATION TRENDS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
- 5.6.2 JURISDICTION & TOP APPLICANT ANALYSIS
- 5.7 TRADE ANALYSIS
- 5.7.1 TRADE DATA FOR HS CODE 9018
- 5.7.1.1 Import data for HS Code 9018
- 5.7.1.2 Export data for HS Code 9018
- 5.7.1 TRADE DATA FOR HS CODE 9018
- 5.8 PRICING ANALYSIS
- 5.8.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022-2024
- 5.8.2 AVERAGE SELLING PRICE, BY REGION, 2022-2024
- 5.8.2.1 Average selling price of ELISA and PCR test kits, by region, 2024
- 5.8.2.2 Average selling price trend of ELISA test kits (per 96-well kit), by region, 2022-2024
- 5.8.2.3 Average selling price trend of lateral flow rapid tests (per unit), by region, 2022-2024
- 5.8.2.4 Average selling price trend of PCR test kits (veterinary panels), by region, 2022-2024
- 5.8.2.5 Average selling price trend of immunoassay analyzers (benchtop), by region, 2022-2024
- 5.8.2.6 Average selling price trend of high-end immunoassay analyzers, by region, 2022-2024
- 5.8.2.7 Average selling price trend of nucleic acid sequencers (benchtop), by region, 2022-2024
- 5.9 REIMBURSEMENT ANALYSIS
- 5.10 KEY CONFERENCES & EVENTS, 2025-2026
- 5.11 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.11.2 BUYING CRITERIA
- 5.12 END-USER PERSPECTIVE & UNMET NEEDS
- 5.13 IMPACT OF AI ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
- 5.13.1 INTRODUCTION
- 5.13.2 MARKET POTENTIAL IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS ECOSYSTEM
- 5.13.3 AI USE CASES
- 5.13.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
- 5.14 ECOSYSTEM ANALYSIS
- 5.15 VALUE CHAIN ANALYSIS
- 5.16 SUPPLY CHAIN ANALYSIS
- 5.17 ADJACENT MARKET ANALYSIS
- 5.18 INVESTMENT & FUNDING SCENARIO
- 5.19 IMPACT OF 2025 US TARIFF ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
- 5.19.1 INTRODUCTION
- 5.19.2 KEY TARIFF RATES
- 5.19.3 PRICE IMPACT ANALYSIS
- 5.19.4 IMPACT ON COUNTRY/REGION
- 5.19.5 IMPACT ON END-USE INDUSTRIES
6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT
- 6.1 INTRODUCTION
- 6.2 CONSUMABLES
- 6.2.1 RECURRENT PURCHASE OF DIAGNOSTIC KITS AND REAGENTS TO BOOST MARKET GROWTH
- 6.3 INSTRUMENTS
- 6.3.1 INCREASING DEMAND FOR POC ANALYZERS TO SUPPORT MARKET GROWTH
7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY
- 7.1 INTRODUCTION
- 7.2 IMMUNODIAGNOSTICS
- 7.2.1 LATERAL FLOW ASSAYS
- 7.2.1.1 Lateral flow rapid tests
- 7.2.1.1.1 Ability to provide real-time insights to drive market
- 7.2.1.2 Lateral flow strip readers
- 7.2.1.2.1 Rising need for readers to determine analyte quantity to fuel adoption
- 7.2.1.1 Lateral flow rapid tests
- 7.2.2 ELISA TESTS
- 7.2.2.1 Cost-effectiveness and ease of use to drive market
- 7.2.3 IMMUNOASSAY ANALYZERS
- 7.2.3.1 High sensitivity & specificity for biomarker detection to drive market
- 7.2.4 OTHER IMMUNODIAGNOSTIC TECHNOLOGIES
- 7.2.1 LATERAL FLOW ASSAYS
- 7.3 MOLECULAR DIAGNOSTICS
- 7.3.1 PCR TESTS
- 7.3.1.1 Increased laboratory usage in proteomics & genomics to support growth
- 7.3.2 NUCLEIC ACID SEQUENCING
- 7.3.2.1 Growing use of nucleic acid sequencing to identify pathogens to fuel market
- 7.3.3 MICROARRAYS
- 7.3.3.1 Growing applications of biochips in identifying infectious diseases to drive market
- 7.3.4 OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES
- 7.3.1 PCR TESTS
- 7.4 OTHER TECHNOLOGIES
8 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE
- 8.1 INTRODUCTION
- 8.2 COMPANION ANIMALS
- 8.2.1 COMPANION ANIMALS MARKET, BY ANIMAL TYPE
- 8.2.1.1 Dogs
- 8.2.1.1.1 High insurance coverage for dogs and rising disposable incomes to drive market
- 8.2.1.2 Cats
- 8.2.1.2.1 Growing pet cat population to support growth
- 8.2.1.3 Horses
- 8.2.1.3.1 Growing equine health awareness to drive market
- 8.2.1.4 Other companion animals
- 8.2.1.1 Dogs
- 8.2.2 COMPANION ANIMALS MARKET, BY TECHNOLOGY
- 8.2.2.1 Immunodiagnostics
- 8.2.2.1.1 Lateral flow assays
- 8.2.2.1.1.1 Rapid results, no requirement for multiple sample batches, and ease of visual reading to drive market growth
- 8.2.2.1.2 ELISA tests
- 8.2.2.1.2.1 High sensitivity, specificity, and precision of ELISA tests to drive market
- 8.2.2.1.3 Immunoassay analyzers
- 8.2.2.1.3.1 Ability to process multiple samples to drive adoption of immunoassay analyzers
- 8.2.2.1.4 Other immunodiagnostic technologies
- 8.2.2.1.1 Lateral flow assays
- 8.2.2.2 Molecular diagnostics
- 8.2.2.2.1 PCR tests
- 8.2.2.2.1.1 Extensive use of PCR due to its high specificity and sensitivity to boost adoption
- 8.2.2.2.2 Nucleic acid sequencing
- 8.2.2.2.2.1 Increasing use of nucleic acid sequencing for pathogen discovery and identification to support growth
- 8.2.2.2.3 Microarrays
- 8.2.2.2.3.1 Technological advancements and increasing incidence of infectious diseases to fuel demand for microarrays
- 8.2.2.2.4 Other molecular diagnostic technologies
- 8.2.2.2.1 PCR tests
- 8.2.2.3 Other technologies
- 8.2.2.1 Immunodiagnostics
- 8.2.1 COMPANION ANIMALS MARKET, BY ANIMAL TYPE
- 8.3 LIVESTOCK
- 8.3.1 LIVESTOCK MARKET, BY ANIMAL TYPE
- 8.3.1.1 Cattle
- 8.3.1.1.1 Growing consumption of meat to support market growth
- 8.3.1.2 Pigs
- 8.3.1.2.1 Growing incidence of infectious diseases to drive market
- 8.3.1.3 Poultry
- 8.3.1.3.1 Increasing demand for poultry meat to contribute to market growth
- 8.3.1.4 Other livestock
- 8.3.1.1 Cattle
- 8.3.2 LIVESTOCK MARKET, BY TECHNOLOGY
- 8.3.2.1 Immunodiagnostics
- 8.3.2.1.1 Lateral flow assays
- 8.3.2.1.1.1 Field-readiness and stakeholder accessibility of LFAs to boost demand
- 8.3.2.1.2 ELISA tests
- 8.3.2.1.2.1 Cost-effectiveness, high sensitivity, and ease of use to drive ELISA market
- 8.3.2.1.3 Immunoassay analyzers
- 8.3.2.1.3.1 High sensitivity & specificity for biomarker detection to drive market
- 8.3.2.1.4 Other immunodiagnostic technologies
- 8.3.2.1.1 Lateral flow assays
- 8.3.2.2 Molecular diagnostics
- 8.3.2.2.1 PCR tests
- 8.3.2.2.1.1 Growing use of PCR in proteomics and genomics to drive market growth
- 8.3.2.2.2 Nucleic acid sequencing
- 8.3.2.2.2.1 Identification of pathogens to fuel market
- 8.3.2.2.3 Microarrays
- 8.3.2.2.3.1 Emergence of biochips and growing applications in identifying infectious diseases to drive growth
- 8.3.2.2.4 Other molecular diagnostic technologies
- 8.3.2.2.1 PCR tests
- 8.3.2.3 Other technologies
- 8.3.2.1 Immunodiagnostics
- 8.3.1 LIVESTOCK MARKET, BY ANIMAL TYPE
9 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER
- 9.1 INTRODUCTION
- 9.2 VETERINARY REFERENCE LABORATORIES
- 9.2.1 LARGE VOLUME OF TESTING SAMPLES AND AVAILABILITY OF SKILLED WORKFORCE TO PROPEL MARKET
- 9.3 VETERINARY HOSPITALS & CLINICS
- 9.3.1 GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO DRIVE MARKET
- 9.4 POINT-OF-CARE/IN-HOUSE TESTING
- 9.4.1 COST-EFFECTIVENESS AND RAPID RESULTS TO BOOST DEMAND
- 9.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
- 9.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND RESEARCH INSTITUTES TO SUPPORT GROWTH
10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION
- 10.1 INTRODUCTION
- 10.2 NORTH AMERICA
- 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 10.2.2 US
- 10.2.2.1 High veterinary healthcare expenditure to drive market
- 10.2.3 CANADA
- 10.2.3.1 Growing pet adoption to drive market
- 10.3 EUROPE
- 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 10.3.2 GERMANY
- 10.3.2.1 Rising awareness of zoonotic diseases to fuel market
- 10.3.3 UK
- 10.3.3.1 Increasing pet ownership to drive market
- 10.3.4 FRANCE
- 10.3.4.1 Willingness of pet owners to spend on pet health to drive market
- 10.3.5 ITALY
- 10.3.5.1 Growing consumption of meat & dairy products to drive market
- 10.3.6 SPAIN
- 10.3.6.1 Growing demand for poultry products to fuel market
- 10.3.7 NETHERLANDS
- 10.3.7.1 Developments in veterinary diagnostic products to support market growth
- 10.3.8 REST OF EUROPE
- 10.4 ASIA PACIFIC
- 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 10.4.2 CHINA
- 10.4.2.1 Increasing incidence of zoonotic diseases to propel market
- 10.4.3 JAPAN
- 10.4.3.1 Increasing pet expenditure to support market growth
- 10.4.4 INDIA
- 10.4.4.1 Increasing demand for dairy products to drive market
- 10.4.5 AUSTRALIA
- 10.4.5.1 Rise in pet ownership to support market growth
- 10.4.6 SOUTH KOREA
- 10.4.6.1 Rising need for specialized veterinary services to drive market
- 10.4.7 NEW ZEALAND
- 10.4.7.1 Focus on pet insurance to aid market
- 10.4.8 VIETNAM
- 10.4.8.1 Growing focus on disease surveillance to drive market
- 10.4.9 REST OF ASIA PACIFIC
- 10.5 LATIN AMERICA
- 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 10.5.2 BRAZIL
- 10.5.2.1 Growth in livestock industry to boost demand
- 10.5.3 MEXICO
- 10.5.3.1 Increasing focus on poultry-associated products to support market growth
- 10.5.4 REST OF LATIN AMERICA
- 10.6 MIDDLE EAST & AFRICA
- 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 10.6.2 GCC COUNTRIES
- 10.6.2.1 Kingdom of Saudi Arabia (KSA)
- 10.6.2.1.1 Technological advancements in veterinary diagnostics to boost demand
- 10.6.2.2 United Arab Emirates (UAE)
- 10.6.2.2.1 Favorable government support for vet diagnostics to drive market
- 10.6.2.3 Rest of GCC Countries
- 10.6.2.1 Kingdom of Saudi Arabia (KSA)
- 10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
- 11.1 OVERVIEW
- 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
- 11.3 REVENUE ANALYSIS, 2020-2024
- 11.4 MARKET SHARE ANALYSIS, 2024
- 11.4.1 MARKET SHARE ANALYSIS FOR COMPANION ANIMALS
- 11.4.2 MARKET SHARE ANALYSIS FOR LIVESTOCK
- 11.4.3 RANKING OF KEY MARKET PLAYERS
- 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 11.5.1 STARS
- 11.5.2 EMERGING LEADERS
- 11.5.3 PERVASIVE PLAYERS
- 11.5.4 PARTICIPANTS
- 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
- 11.5.5.1 Company footprint
- 11.5.5.2 Region footprint
- 11.5.5.3 Product footprint
- 11.5.5.4 Technology footprint
- 11.5.5.5 Animal type footprint
- 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 11.6.1 PROGRESSIVE COMPANIES
- 11.6.2 RESPONSIVE COMPANIES
- 11.6.3 DYNAMIC COMPANIES
- 11.6.4 STARTING BLOCKS
- 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
- 11.6.5.1 Detailed list of key startups/SMEs
- 11.6.5.2 Competitive benchmarking of key startups
- 11.7 BRAND/PRODUCT COMPARISON
- 11.8 R&D EXPENDITURE OF KEY PLAYERS
- 11.9 COMPANY VALUATION & FINANCIAL METRICS
- 11.9.1 FINANCIAL METRICS
- 11.9.2 COMPANY VALUATION
- 11.10 COMPETITIVE SCENARIO
- 11.10.1 PRODUCT LAUNCHES & ENHANCEMENTS
- 11.10.2 DEALS
- 11.10.3 EXPANSIONS
- 11.10.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
- 12.1 KEY PLAYERS
- 12.1.1 IDEXX LABORATORIES, INC.
- 12.1.1.1 Business overview
- 12.1.1.2 Products & services offered
- 12.1.1.3 Recent developments
- 12.1.1.3.1 Product/Service launches & enhancements
- 12.1.1.4 MnM view
- 12.1.1.4.1 Key strengths
- 12.1.1.4.2 Strategic choices
- 12.1.1.4.3 Weaknesses & competitive threats
- 12.1.2 ZOETIS SERVICES LLC
- 12.1.2.1 Business overview
- 12.1.2.2 Products & services offered
- 12.1.2.3 Recent developments
- 12.1.2.3.1 Product enhancements
- 12.1.2.3.2 Deals
- 12.1.2.3.3 Expansions
- 12.1.2.4 MnM view
- 12.1.2.4.1 Key strengths
- 12.1.2.4.2 Strategic choices
- 12.1.2.4.3 Weaknesses & competitive threats
- 12.1.3 THERMO FISHER SCIENTIFIC INC.
- 12.1.3.1 Business overview
- 12.1.3.2 Products & services offered
- 12.1.3.3 MnM view
- 12.1.3.3.1 Key strengths
- 12.1.3.3.2 Strategic choices
- 12.1.3.3.3 Weaknesses & competitive threats
- 12.1.4 VIRBAC
- 12.1.4.1 Business overview
- 12.1.4.2 Products & services offered
- 12.1.4.3 Recent developments
- 12.1.4.3.1 Deals
- 12.1.4.3.2 Expansions
- 12.1.4.4 MnM view
- 12.1.4.4.1 Key strengths
- 12.1.4.4.2 Strategic choices
- 12.1.4.4.3 Weaknesses & competitive threats
- 12.1.5 BIOMERIEUX
- 12.1.5.1 Business overview
- 12.1.5.2 Products & services offered
- 12.1.5.3 Recent developments
- 12.1.5.3.1 Product launches & approvals
- 12.1.5.4 MnM view
- 12.1.5.4.1 Key strengths
- 12.1.5.4.2 Strategic choices
- 12.1.5.4.3 Weaknesses & competitive threats
- 12.1.6 ANTECH DIAGNOSTICS, INC.
- 12.1.6.1 Business overview
- 12.1.6.2 Products & services offered
- 12.1.6.3 Recent developments
- 12.1.6.3.1 Product launches
- 12.1.6.3.2 Expansions
- 12.1.7 INNOVATIVE DIAGNOSTICS
- 12.1.7.1 Business overview
- 12.1.7.2 Products & services offered
- 12.1.8 NEOGEN CORPORATION
- 12.1.8.1 Business overview
- 12.1.8.2 Products & services offered
- 12.1.8.2.1 Other developments
- 12.1.9 INDICAL BIOSCIENCE GMBH
- 12.1.9.1 Business overview
- 12.1.9.2 Products & services offered
- 12.1.9.3 Recent developments
- 12.1.9.3.1 Product enhancements
- 12.1.10 AGROLABO S.P.A.
- 12.1.10.1 Business overview
- 12.1.10.2 Products & services offered
- 12.1.11 BIONOTE
- 12.1.11.1 Business overview
- 12.1.11.2 Products & services offered
- 12.1.11.3 Recent developments
- 12.1.11.4 Product launches
- 12.1.11.4.1 Deals
- 12.1.12 BIOGAL
- 12.1.12.1 Business overview
- 12.1.12.2 Products & services offered
- 12.1.13 BIOCHEK
- 12.1.13.1 Business overview
- 12.1.13.2 Products & services offered
- 12.1.13.3 Recent developments
- 12.1.13.3.1 Product launches
- 12.1.13.3.2 Deals
- 12.1.14 MEGACOR DIAGNOSTIK GMBH
- 12.1.14.1 Business overview
- 12.1.14.2 Products & services offered
- 12.1.14.3 Recent developments
- 12.1.14.3.1 Product launches & enhancements
- 12.1.15 BIO-RAD LABORATORIES, INC.
- 12.1.15.1 Business overview
- 12.1.15.2 Products & services offered
- 12.1.1 IDEXX LABORATORIES, INC.
- 12.2 OTHER PLAYERS
- 12.2.1 FASSISI, GMBH
- 12.2.2 BIOTANGENTS LIMITED
- 12.2.3 SKYER, INC.
- 12.2.4 BIOPANDA REAGENTS LTD.
- 12.2.5 SHENZHEN BIOEASY BIOTECHNOLOGY, INC.
- 12.2.6 GOLD STANDARD DIAGNOSTICS
- 12.2.7 BIO-X DIAGNOSTICS S.A.
- 12.2.8 DEMEDITEC DIAGNOSTICS GMBH
- 12.2.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
- 12.2.10 BIOSTONE ANIMAL HEALTH
13 APPENDIX
- 13.1 DISCUSSION GUIDE
- 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 13.3 RELATED REPORTS
- 13.4 AUTHOR DETAILS
List of Tables
- TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD)
- TABLE 2 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ASSUMPTIONS ANALYSIS
- TABLE 3 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS
- TABLE 4 NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024, BY ANIMAL TYPE (MILLIONS)
- TABLE 5 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009-2023)
- TABLE 6 AVERAGE PREMIUMS PAID IN US, 2020 VS. 2023
- TABLE 7 NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012-2023) (USD MILLION)
- TABLE 8 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
- TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 12 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: MAJOR PATENTS
- TABLE 13 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020-2023 (USD THOUSAND)
- TABLE 14 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020-2023 (USD THOUSAND)
- TABLE 15 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022-2024
- TABLE 16 AVERAGE SELLING PRICE TREND OF ELISA TEST KITS (PER 96-WELL KIT), BY REGION, 2022-2024
- TABLE 17 AVERAGE SELLING PRICE TREND OF LATERAL FLOW RAPID TESTS (PER UNIT), BY REGION, 2022-2024
- TABLE 18 AVERAGE SELLING PRICE TREND OF PCR TEST KITS (VETERINARY PANELS), BY REGION, 2022-2024
- TABLE 19 AVERAGE SELLING PRICE TREND OF IMMUNOASSAY ANALYZER (BENCHTOP), BY REGION, 2022-2024
- TABLE 20 AVERAGE SELLING PRICE TREND OF HIGH-END IMMUNOASSAY ANALYZERS, BY REGION, 2022-2024
- TABLE 21 AVERAGE SELLING PRICE TREND OF NUCLEIC ACID SEQUENCERS (BENCHTOP) BY REGION, 2022-2024
- TABLE 22 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: KEY CONFERENCES & EVENTS, 2025-2026
- TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS (%)
- TABLE 24 KEY BUYING CRITERIA FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
- TABLE 25 KEY COMPANIES IMPLEMENTING AI IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
- TABLE 26 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
- TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES
- TABLE 28 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
- TABLE 29 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
- TABLE 30 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
- TABLE 31 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
- TABLE 32 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
- TABLE 33 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 34 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 35 KEY PLAYERS OFFERING VETERINARY INFECTIOUS DISEASE DIAGNOSTIC CONSUMABLES
- TABLE 36 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 37 KEY PLAYERS PROVIDING VETERINARY INFECTIOUS DISEASE DIAGNOSTIC INSTRUMENTS
- TABLE 38 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 39 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 40 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES
- TABLE 41 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 42 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 43 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS
- TABLE 44 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY REGION, 2023-2030 (THOUSAND UNITS)
- TABLE 45 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 46 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 47 KEY PLAYERS PROVIDING LATERAL FLOW RAPID TESTS
- TABLE 48 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW RAPID TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 49 KEY PLAYERS PROVIDING LATERAL FLOW STRIP READERS
- TABLE 50 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW STRIP READERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 51 KEY PLAYERS PROVIDING ELISA TESTS
- TABLE 52 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ELISA TESTS, BY REGION, 2023-2030 (THOUSAND UNITS)
- TABLE 53 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ELISA TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 54 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS
- TABLE 55 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNOASSAY ANALYZERS, BY REGION, 2023-2030 (THOUSAND UNITS)
- TABLE 56 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 57 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES
- TABLE 58 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 59 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTIC TESTS
- TABLE 60 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 61 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 62 KEY PLAYERS PROVIDING PCR TESTS
- TABLE 63 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR TESTS, BY REGION, 2023-2030 (THOUSAND UNITS)
- TABLE 64 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 65 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING
- TABLE 66 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY REGION, 2023-2030 (THOUSAND UNITS)
- TABLE 67 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 68 KEY PLAYERS PROVIDING MICROARRAYS
- TABLE 69 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MICROARRAYS, BY REGION, 2023-2030 (THOUSAND UNITS)
- TABLE 70 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MICROARRAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 71 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES
- TABLE 72 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 73 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES
- TABLE 74 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 75 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 76 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR COMPANION ANIMALS
- TABLE 77 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 78 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 79 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR DOGS
- TABLE 80 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 81 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR CATS
- TABLE 82 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 83 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR HORSES
- TABLE 84 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 85 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR OTHER COMPANION ANIMALS
- TABLE 86 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 87 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 88 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS
- TABLE 89 COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 90 COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 91 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS FOR COMPANION ANIMALS
- TABLE 92 COMPANION ANIMALS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 93 KEY PLAYERS PROVIDING ELISA TESTS FOR COMPANION ANIMALS
- TABLE 94 COMPANION ANIMALS MARKET FOR ELISA TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 95 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS FOR COMPANION ANIMALS
- TABLE 96 COMPANION ANIMALS MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 97 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS
- TABLE 98 COMPANION ANIMALS MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 99 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS FOR COMPANION ANIMALS
- TABLE 100 COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 101 COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 102 KEY PLAYERS PROVIDING PCR TESTS FOR COMPANION ANIMALS
- TABLE 103 COMPANION ANIMALS MARKET FOR PCR TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 104 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING FOR COMPANION ANIMALS
- TABLE 105 COMPANION ANIMALS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 106 KEY PLAYERS PROVIDING MICROARRAYS FOR COMPANION ANIMALS
- TABLE 107 COMPANION ANIMALS MARKET FOR MICROARRAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 108 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS
- TABLE 109 COMPANION ANIMALS MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 110 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES FOR COMPANION ANIMALS
- TABLE 111 COMPANION ANIMALS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 112 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR LIVESTOCK
- TABLE 113 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 114 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 115 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR CATTLE
- TABLE 116 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 117 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR PIGS
- TABLE 118 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 119 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR POULTRY
- TABLE 120 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 121 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR OTHER LIVESTOCK ANIMALS
- TABLE 122 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER LIVESTOCK, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 123 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 124 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK
- TABLE 125 LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 126 LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 127 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS FOR LIVESTOCK
- TABLE 128 LIVESTOCK MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 129 KEY PLAYERS PROVIDING ELISA TESTS FOR LIVESTOCK
- TABLE 130 LIVESTOCK MARKET FOR ELISA TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 131 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS FOR LIVESTOCK
- TABLE 132 LIVESTOCK MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 133 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK
- TABLE 134 LIVESTOCK MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 135 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS FOR LIVESTOCK
- TABLE 136 LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 137 LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 138 KEY PLAYERS PROVIDING PCR TESTS FOR LIVESTOCK
- TABLE 139 LIVESTOCK MARKET FOR PCR TESTS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 140 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING FOR LIVESTOCK
- TABLE 141 LIVESTOCK MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 142 KEY PLAYERS PROVIDING MICROARRAYS FOR LIVESTOCK
- TABLE 143 LIVESTOCK MARKET FOR MICROARRAYS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 144 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK
- TABLE 145 LIVESTOCK MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 146 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES FOR LIVESTOCK
- TABLE 147 LIVESTOCK MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 148 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 149 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 150 BASIC ANNUAL EXPENSES FOR CATS & DOGS IN US, 2023 (USD)
- TABLE 151 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 152 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 153 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 154 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 155 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 156 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 157 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 158 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 159 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 160 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 161 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 162 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 163 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 164 NORTH AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 165 NORTH AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 166 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 167 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 168 NORTH AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 169 NORTH AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 170 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 171 US: KEY MACROINDICATORS
- TABLE 172 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 173 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 174 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 175 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 176 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 177 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 178 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 179 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 180 US: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 181 US: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 182 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 183 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 184 US: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 185 US: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 186 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 187 CANADA: KEY MACROINDICATORS
- TABLE 188 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 189 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 190 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 191 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 192 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 193 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 194 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 195 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 196 CANADA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 197 CANADA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 198 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 199 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 200 CANADA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 201 CANADA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 202 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 203 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 204 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 205 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 206 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 207 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 208 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 209 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 210 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 211 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 212 EUROPE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 213 EUROPE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 214 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 215 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 216 EUROPE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 217 EUROPE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 218 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 219 GERMANY: KEY MACROINDICATORS
- TABLE 220 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 221 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 222 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 223 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 224 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 225 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 226 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 227 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 228 GERMANY: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 229 GERMANY: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 230 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 231 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 232 GERMANY: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 233 GERMANY: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 234 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 235 UK: KEY MACROINDICATORS
- TABLE 236 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 237 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 238 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 239 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 240 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 241 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 242 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 243 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 244 UK: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 245 UK: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 246 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 247 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 248 UK: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 249 UK: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 250 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 251 FRANCE: KEY MACROINDICATORS
- TABLE 252 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 253 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 254 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 255 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 256 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 257 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 258 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 259 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 260 FRANCE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 261 FRANCE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 262 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 263 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 264 FRANCE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 265 FRANCE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 266 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 267 ITALY: KEY MACROINDICATORS
- TABLE 268 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 269 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 270 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 271 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 272 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 273 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 274 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 275 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 276 ITALY: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 277 ITALY: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 278 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 279 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 280 ITALY: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 281 ITALY: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 282 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 283 SPAIN: KEY MACROINDICATORS
- TABLE 284 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 285 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 286 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 287 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 288 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 289 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 290 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 291 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 292 SPAIN: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 293 SPAIN: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 294 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 295 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 296 SPAIN: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 297 SPAIN: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 298 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 299 NETHERLANDS: KEY MACROINDICATORS
- TABLE 300 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 301 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 302 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 303 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 304 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 305 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 306 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 307 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 308 NETHERLANDS: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 309 NETHERLANDS: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 310 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 311 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 312 NETHERLANDS: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 313 NETHERLANDS: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 314 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 315 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 316 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 317 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 318 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 319 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 320 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 321 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 322 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 323 REST OF EUROPE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 324 REST OF EUROPE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 325 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 326 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 327 REST OF EUROPE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 328 REST OF EUROPE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 329 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 330 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 331 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 332 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 333 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 334 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 335 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 336 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 337 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 338 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 339 ASIA PACIFIC: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 340 ASIA PACIFIC: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 341 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 342 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 343 ASIA PACIFIC: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 344 ASIA PACIFIC: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 345 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 346 CHINA: KEY MACROINDICATORS
- TABLE 347 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 348 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 349 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 350 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 351 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 352 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 353 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 354 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 355 CHINA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 356 CHINA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 357 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 358 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 359 CHINA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 360 CHINA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 361 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 362 JAPAN: KEY MACROINDICATORS
- TABLE 363 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 364 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 365 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 366 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 367 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 368 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 369 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 370 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 371 JAPAN: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 372 JAPAN: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 373 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 374 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 375 JAPAN: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 376 JAPAN: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 377 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 378 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
- TABLE 379 INDIA: KEY MACROINDICATORS
- TABLE 380 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 381 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 382 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 383 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 384 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 385 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 386 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 387 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 388 INDIA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 389 INDIA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 390 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 391 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 392 INDIA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 393 INDIA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 394 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 395 AUSTRALIA: KEY MACROINDICATORS
- TABLE 396 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 397 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 398 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 399 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 400 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 401 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 402 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 403 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 404 AUSTRALIA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 405 AUSTRALIA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 406 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 407 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 408 AUSTRALIA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 409 AUSTRALIA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 410 AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 411 SOUTH KOREA: KEY MACROINDICATORS
- TABLE 412 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 413 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 414 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 415 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 416 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 417 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 418 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 419 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 420 SOUTH KOREA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 421 SOUTH KOREA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 422 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 423 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 424 SOUTH KOREA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 425 SOUTH KOREA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 426 SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 427 NEW ZEALAND: KEY MACROINDICATORS
- TABLE 428 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 429 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 430 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 431 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 432 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 433 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 434 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 435 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 436 NEW ZEALAND: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 437 NEW ZEALAND: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 438 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 439 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 440 NEW ZEALAND: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 441 NEW ZEALAND: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 442 NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 443 VIETNAM: KEY MACROINDICATORS
- TABLE 444 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 445 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 446 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 447 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 448 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 449 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 450 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 451 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 452 VIETNAM: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 453 VIETNAM: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 454 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 455 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 456 VIETNAM: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 457 VIETNAM: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 458 VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 459 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 460 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 461 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 462 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 463 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 464 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 465 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 466 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 467 REST OF ASIA PACIFIC: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 468 REST OF ASIA PACIFIC: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 469 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 470 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 471 REST OF ASIA PACIFIC: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 472 REST OF ASIA PACIFIC: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 473 REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 474 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 475 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 476 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 477 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 478 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 479 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 480 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 481 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 482 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 483 LATIN AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 484 LATIN AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 485 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 486 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 487 LATIN AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 488 LATIN AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 489 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 490 BRAZIL: KEY MACROINDICATORS
- TABLE 491 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 492 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 493 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 494 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 495 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 496 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 497 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 498 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 499 BRAZIL: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 500 BRAZIL: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 501 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 502 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 503 BRAZIL: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 504 BRAZIL: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 505 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 506 MEXICO: KEY MACROINDICATORS
- TABLE 507 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 508 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 509 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 510 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 511 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 512 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 513 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 514 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 515 MEXICO: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 516 MEXICO: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 517 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 518 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 519 MEXICO: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 520 MEXICO: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 521 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 522 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 523 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 524 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 525 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 526 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 527 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 528 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 529 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 530 REST OF LATIN AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 531 REST OF LATIN AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 532 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 533 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 534 REST OF LATIN AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 535 REST OF LATIN AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 536 REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 537 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 538 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 539 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 540 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 541 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 542 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 543 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 544 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 545 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 546 MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 547 MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 548 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 549 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 550 MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, B Y TYPE, 2023-2030 (USD MILLION)
- TABLE 551 MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 552 MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 553 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 554 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 555 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 556 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 557 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 558 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 559 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 560 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 561 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 562 GCC COUNTRIES: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 563 GCC COUNTRIES: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 564 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 565 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 566 GCC COUNTRIES: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 567 GCC COUNTRIES: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 568 GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 569 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS
- TABLE 570 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 571 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 572 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 573 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 574 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 575 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 576 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 577 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 578 KINGDOM OF SAUDI ARABIA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 579 KINGDOM OF SAUDI ARABIA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 580 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 581 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 582 KINGDOM OF SAUDI ARABIA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 583 KINGDOM OF SAUDI ARABIA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 584 KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 585 UNITED ARAB EMIRATES: KEY MACROINDICATORS
- TABLE 586 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 587 UNITED ARAB EMIRATES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 588 UNITED ARAB EMIRATES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 589 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 590 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 591 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 592 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 593 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 594 UNITED ARAB EMIRATES: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 595 UNITED ARAB EMIRATES: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 596 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 597 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 598 UNITED ARAB EMIRATES: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 599 UNITED ARAB EMIRATES: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 600 UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 601 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 602 REST OF GCC COUNTRIES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 603 REST OF GCC COUNTRIES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 604 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 605 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 606 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 607 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 608 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 609 REST OF GCC COUNTRIES: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 610 REST OF GCC COUNTRIES: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 611 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 612 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 613 REST OF GCC COUNTRIES: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 614 REST OF GCC COUNTRIES: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 615 REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 616 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 617 REST OF MIDDLE EAST & AFRICA : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 618 REST OF MIDDLE EAST & AFRICA : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 619 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 620 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 621 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023-2030 (USD MILLION)
- TABLE 622 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 623 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 624 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 625 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 626 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 627 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 628 REST OF MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 629 REST OF MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 630 REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 631 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
- TABLE 632 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS: DEGREE OF COMPETITION
- TABLE 633 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK: DEGREE OF COMPETITION
- TABLE 634 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: REGION FOOTPRINT
- TABLE 635 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PRODUCT FOOTPRINT
- TABLE 636 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: TECHNOLOGY FOOTPRINT
- TABLE 637 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ANIMAL TYPE FOOTPRINT
- TABLE 638 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
- TABLE 639 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS
- TABLE 640 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-MAY 2025
- TABLE 641 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEALS, JANUARY 2022-MAY 2025
- TABLE 642 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2022-MAY 2025
- TABLE 643 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025
- TABLE 644 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW
- TABLE 645 IDEXX LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
- TABLE 646 IDEXX LABORATORIES, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2022-MAY 2025
- TABLE 647 ZOETIS SERVICES LLC: COMPANY OVERVIEW
- TABLE 648 ZOETIS SERVICES LLC: PRODUCTS & SERVICES OFFERED
- TABLE 649 ZOETIS SERVICES LLC: PRODUCT ENHANCEMENTS, JANUARY 2022-MAY 2025
- TABLE 650 ZOETIS SERVICES LLC: DEALS, JANUARY 2022-APRIL 2025
- TABLE 651 ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2022-MAY 2025
- TABLE 652 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
- TABLE 653 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
- TABLE 654 VIRBAC: COMPANY OVERVIEW
- TABLE 655 VIRBAC: PRODUCTS & SERVICES OFFERED
- TABLE 656 VIRBAC: DEALS, JANUARY 2022-MAY 2025
- TABLE 657 VIRBAC: EXPANSIONS, JANUARY 2022-MAY 2025
- TABLE 658 BIOMERIEUX: COMPANY OVERVIEW
- TABLE 659 BIOMERIEUX: PRODUCTS & SERVICES OFFERED
- TABLE 660 BIOMERIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2025
- TABLE 661 ANTECH DIAGNOSTICS, INC.: COMPANY OVERVIEW
- TABLE 662 ANTECH DIAGNOSTICS, INC.: PRODUCTS & SERVICES OFFERED
- TABLE 663 ANTECH DIAGNOSTICS, INC.: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
- TABLE 664 ANTECH DIAGNOSTICS, INC.: EXPANSIONS, JANUARY 2022-MAY 2025
- TABLE 665 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW
- TABLE 666 INNOVATIVE DIAGNOSTICS: PRODUCTS & SERVICES OFFERED
- TABLE 667 NEOGEN CORPORATION: COMPANY OVERVIEW
- TABLE 668 NEOGEN CORPORATION: PRODUCTS & SERVICES OFFERED
- TABLE 669 NEOGEN CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2025
- TABLE 670 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW
- TABLE 671 INDICAL BIOSCIENCE GMBH: PRODUCTS & SERVICES OFFERED
- TABLE 672 INDICAL BIOSCIENCE GMBH: PRODUCT ENHANCEMENTS, JANUARY 2022-MAY 2025
- TABLE 673 AGROLABO S.P.A.: COMPANY OVERVIEW
- TABLE 674 AGROLABO S.P.A.: PRODUCTS & SERVICES OFFERED
- TABLE 675 BIONOTE: COMPANY OVERVIEW
- TABLE 676 BIONOTE: PRODUCTS & SERVICES OFFERED
- TABLE 677 BIONOTE: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
- TABLE 678 BIONOTE: DEALS, JANUARY 2022-MAY 2025
- TABLE 679 BIOGAL: COMPANY OVERVIEW
- TABLE 680 BIOGAL: PRODUCTS & SERVICES OFFERED
- TABLE 681 BIOCHEK: COMPANY OVERVIEW
- TABLE 682 BIOCHEK: PRODUCTS & SERVICES OFFERED
- TABLE 683 BIOCHEK: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
- TABLE 684 BIOCHEK: DEALS, JANUARY 2022-MAY 2025
- TABLE 685 MEGACOR DIAGNOSTIK GMBH: COMPANY OVERVIEW
- TABLE 686 MEGACOR DIAGNOSTIK GMBH: PRODUCTS & SERVICES OFFERED
- TABLE 687 MEGACOR DIAGNOSTIK GMBH: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-MAY 2025
- TABLE 688 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
- TABLE 689 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
- TABLE 690 FASSISI, GMBH: COMPANY OVERVIEW
- TABLE 691 BIOTANGENTS LIMITED: COMPANY OVERVIEW
- TABLE 692 SKYER, INC.: COMPANY OVERVIEW
- TABLE 693 BIOPANDA REAGENTS LTD.: COMPANY OVERVIEW
- TABLE 694 SHENZHEN BIOEASY BIOTECHNOLOGY, INC.: COMPANY OVERVIEW
- TABLE 695 GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW
- TABLE 696 BIO-X DIAGNOSTICS S.A.: COMPANY OVERVIEW
- TABLE 697 DEMEDITEC DIAGNOSTICS GMBH: COMPANY OVERVIEW
- TABLE 698 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG: COMPANY OVERVIEW
- TABLE 699 BIOSTONE ANIMAL HEALTH: COMPANY OVERVIEW
List of Figures
- FIGURE 1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION & REGIONAL SCOPE
- FIGURE 2 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCH DESIGN
- FIGURE 3 PRIMARY SOURCES
- FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
- FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE)
- FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
- FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
- FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
- FIGURE 9 REVENUE ANALYSIS OF TOP FIVE COMPANIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2024)
- FIGURE 10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS
- FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2025-2030)
- FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
- FIGURE 13 TOP-DOWN APPROACH
- FIGURE 14 BOTTOM-UP APPROACH
- FIGURE 15 MARKET DATA TRIANGULATION METHODOLOGY
- FIGURE 16 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
- FIGURE 17 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
- FIGURE 18 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION)
- FIGURE 19 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2025 VS. 2030 (USD MILLION)
- FIGURE 20 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
- FIGURE 21 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2025 VS. 2030 (USD MILLION)
- FIGURE 22 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
- FIGURE 23 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
- FIGURE 24 GEOGRAPHIC SNAPSHOT OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
- FIGURE 25 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO FUEL MARKET GROWTH
- FIGURE 26 CONSUMABLES SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARES IN 2024
- FIGURE 27 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
- FIGURE 28 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
- FIGURE 29 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
- FIGURE 30 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 31 EUROPE: PET POPULATION, 2021-2023
- FIGURE 32 US: PET EXPENDITURE, DOGS VS. CATS, 2024 (USD)
- FIGURE 33 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 34 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014-MAY 2025)
- FIGURE 35 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2014-MAY 2025)
- FIGURE 36 AVERAGE SELLING PRICE TREND FOR ELISA TEST KITS AND PCR TEST KITS, BY KEY PLAYER, 2024
- FIGURE 37 AVERAGE SELLING PRICE OF ELISA AND PCR TEST KITS, BY REGION, 2024
- FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
- FIGURE 39 KEY BUYING CRITERIA FOR TOP THREE END USERS
- FIGURE 40 AI USE CASES
- FIGURE 41 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP
- FIGURE 42 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
- FIGURE 43 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 44 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ADJACENT MARKETS
- FIGURE 45 INVESTMENT AND FUNDING SCENARIO FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET PLAYERS, 2020-2024
- FIGURE 46 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT
- FIGURE 47 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA, 2012-2030
- FIGURE 48 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
- FIGURE 49 ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024
- FIGURE 50 ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024
- FIGURE 51 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
- FIGURE 52 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020-2024)
- FIGURE 53 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS (2024)
- FIGURE 54 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK (2024)
- FIGURE 55 RANKING OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2024
- FIGURE 56 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
- FIGURE 57 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY FOOTPRINT
- FIGURE 58 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
- FIGURE 59 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
- FIGURE 60 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2022-2024
- FIGURE 61 EV/EBITDA OF KEY VENDORS
- FIGURE 62 YEAR-TO-DATE (YTD) PRICE OF TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 63 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
- FIGURE 64 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2024)
- FIGURE 65 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
- FIGURE 66 VIRBAC: COMPANY SNAPSHOT (2024)
- FIGURE 67 BIOMERIEUX: COMPANY SNAPSHOT (2024)
- FIGURE 68 NEOGEN CORPORATION: COMPANY SNAPSHOT (2024)
- FIGURE 69 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
02-2729-4219
+886-2-2729-4219
2025年兽医感染疾病诊断全球市场报告2025年狂犬病诊断全球市场报告
全球动物感染疾病诊断市场：2025年至2030年预测
全球动物感染疾病诊断市场：市场规模、份额、趋势分析（按动物、技术、产品、感染疾病、最终用途和地区）、细分市场预测（2025-2030 年）
动物感染疾病诊断市场规模、份额和成长分析（按感染类型、技术、动物类型、最终用户和地区）- 产业预测，2025-2032 年
兽医传染病诊断市场 - 全球产业规模、份额、趋势、机会和预测，按技术、动物类型、最终用户、地区和竞争细分，2020-2030F
兽医感染疾病诊断市场：按技术、动物类型、感染类型、最终用户分类 - 2025-2030 年全球预测
2024-2032 年按技术、动物类型、感染类型、最终用户和地区分類的兽医传染病诊断市场报告狂犬病诊断市场、机会、成长动力、产业趋势分析与预测，2024-2032
动物传染病诊断市场评估：依技术、动物类型、感染类型、最终用户和地区划分的机会和预测（2017-2031）
▼